Emicizumab is indicated for prophylaxis in people with severe haemophilia A with and without inhibitors. This case report presents a 29‐year‐old patient, who was recently started on emicizumab prophylaxis, was referred from haematology to the oral and maxillofacial department for dental extractions. The patient had both upper right premolars extracted under local anaesthetic with only tranexamic acid and local measures to manage post‐operative bleeding. There was minimal bleeding post‐operatively with the patient maintaining a stable blood clot and requiring no further intervention. This report also reviews the current guidance available for the surgical management of patients on emicizumab prophylaxis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.